Results 1 to 10 of about 90 (73)
Evaluation of pharmacological correction of L-name-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin Detralex 1000 mg [PDF]
Research Results in Pharmacology, 2018 Introduction. Chronic venous diseases are one of the urgent problems of modern medicine. Recent studies have shown high significance of endothelial dysfunction (ED) and oxidative stress in their pathogenesis.
Yulia Lukyanova +3 more
doaj +11 more sources
Фармация и фармакология (Пятигорск), 2021 Micronized purified flavonoid fraction (MPFF) is the original phlebotropic drug. Its marketed form (Detralex®) consists of 90% diosmin and 10% of other flavonoids. Calculated as hesperidin, it is the most widely used drug today.
E. F. Stepanova +4 more
doaj +2 more sources
Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis. [PDF]
Case Rep Obstet Gynecol, 2013 The 27‐year‐old pregnant woman has been overweight since her childhood. Endocrinological assessments did not confirm hormonal disease. Her pregnancy was without complication. A signs of intrauterine distress were observed and elective caesarean section was performed under heparin protection because of anatomy unsuitable for delivery per vias naturals ...
Horváth B, Skrapits J, Bódis J.
europepmc +2 more sources
Фармация и фармакология (Пятигорск), 2021 The aim of the experiment was to determine the effectiveness of the combined use of trimetazidine and a purified micronized flavonoid fraction, as well as their combinations with methyldopa, in comparison with monotherapy with the same drugs in the ...
O. E. Antsiferova +6 more
doaj +2 more sources
Direct correlation between compression stockings and venotonics (Diosmins) and flow vein diseases in stomatology students [PDF]
Tehnika, 2017 Diseases of veins are considered one of the most common diseases of modern man, right after caries of teeth. Those diseases usually come to exist as a result of genetic and/or other pre-dispositioning factors, however, in most cases, those factors can be
Marinković Violeta M. +3 more
doaj +3 more sources
Амбулаторная хирургия, 2023 Introduction. As there is insufficient evidence to date to determine phlebotropic drug preferences, further research in this area is warranted. Aim.
A. V. Buzlama +3 more
doaj +1 more source
Pharmacotherapy of chronic vein diseases. New European guidelines
Амбулаторная хирургия, 2018 The 19th Annual Meeting of the European Venous Forum held in the city of Athens in 28-30 June 2018 presented the long-awaited updated guidelines for the diagnosis and treatment of chronic venous diseases (CVD), the full text of which can be found in the ...
V. Yu. Bogachev +2 more
doaj +1 more source
Амбулаторная хирургия, 2019 This review examines the development of endothelial dysfunction in chronic venous diseases (СVD), the multifactority of this process. The important role of the nitric oxide system as a universal modulator of various biochemical reactions and realization
A. V. Voronkov, O. Yu. Gamzeleva
doaj +1 more source
Combined use of oral and topical forms of phlebotonics after endovasal laser coagulation
Амбулаторная хирургияIntroduction. The combination of endovasal laser coagulation and miniphlebectomy is actively used in the treatment of Chronic venous diseases, however, the question of improving the management of such patients in the postoperative period remains actual ...
Yu. M. Chubirko, I. O. Kasyanov
doaj +1 more source
Diagnosis and treatment of chronic venous disease
Амбулаторная хирургия, 2016 An overview of the new guideLines of the European Society for VascuLar Surgery. Non-surgicaL (conservative) treatments of chronic venous diseases (CVD) of various cLinicaL cLasses are of paramount importance due to their versatiLity and affordabiLity ...
V. Y. Bogachev +2 more
doaj